Glaukos (GKOS) Stock Forecast & Price Target

GKOS price $236.10 +54.67 +30.13%

Ticker
GKOS
Price
$236.10
Change
+54.67 +30.13%
Market cap ?
$13.93B
P/E ?
-55.74
Forward P/E ?
451.27
Dividend yield ?
0.00%
Beta ?
0.69
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
50
Value
35
Quality
51
Growth
64

Stocklytics score rationale: value 35, quality 51, growth 64.

Financials

2016201720182019202020212022202320242025
114397000159254000181278000236984000224959000294011000282862000314711000383481000507442000

Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat…

Forecast

Consensus Buy from 14 analysts. Average price target $192.90, -18.3% versus the current price. Low $150.00. High $215.00.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Analysts have an average 12-month price target of $192.90 for Glaukos (GKOS), 19.5% below the current price of $239.50. Of 14 analysts covering the stock, 13 rate it Buy or Strong Buy, 1 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.

Forecasts are third-party estimates and often wrong. They are not investment advice.

GKOS price target

12-month price target
Low$150.00
Average$192.90
High$215.00

The average is 19.5% below the current price of $239.50.

Is Glaukos a buy or sell?

Of 14 analysts, 13 rate Glaukos Buy or Strong Buy, 1 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.

Glaukos earnings and revenue forecast

Analyst averages on file: 2026, EPS -0.30, revenue $691.66 million. 2027, EPS $0.52, revenue $852.44 million.

GKOS score and fair value

The Stocklytics Score for GKOS is 50 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.

GKOS forecast FAQs

What is the GKOS price target?

$192.90 average, with a published range of $150.00 to $215.00.

Is Glaukos a buy or sell?

The consensus is Buy from 14 analysts. This is not a recommendation.

What is the Glaukos stock forecast for 2026?

Analysts' average EPS estimate for 2026 on file is -0.30. The average revenue estimate is $691.66 million.

What will GKOS be worth in 2030?

No reliable forecast exists that far out.

When is Glaukos's next earnings report?

The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.

Related: Glaukos · Financials · Dividends · Compare · AI stocks

Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.

Glaukos (GKOS) Stock Forecast & Price Target

GKOS$236.10+54.67 +30.13%

$13.93B

Market Cap

-55.74

P/E

451.27

Forward P/E

50

Score

Price History